trial · primary record
Bleximenib
Leukemia, Myeloid, Acute
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 600 |
| Primary completion | 2029-08-15 |
| Primary endpoint | Percentage of Participants who Achieve Complete Remission (CR) |
| Registry ID | NCT06852222 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:45.487Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06852222
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.